Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Breast Cancer Health Center

Font Size

Celebrex: Lower Breast Cancer Risk?

But Heart Safety Questions Remain

71% Reduced Breast Cancer Risk continued...

Researcher Randal Harris, MD, PhD, and colleagues at Ohio State University adjusted for these breast cancer risk factors in their study and concluded that women who used standard doses of either Vioxx or Celebrex every day for two years had a 71% reduction in breast cancer risk.

Taking two or more pills a week of regular aspirin (325 milligrams) had about a 50% reduction in risk, and the risk reduction for users of ibuprofen (such as Motrin or Advil) or naproxen (such Aleve or Naprosyn) was 63%. Baby aspirin (81 milligrams) and Tylenol (a common pain reliever that is not an NSAID) did not show any effect on risk.

The findings are published in the latest issue of the journal BMC Cancer.

More Study Needed

Given the cardiovascular concerns about Cox-2 inhibitors, Harris says much more research is needed before they can be recommended for cancer prevention.

He adds that newer and safer formulations of the current drugs may be on the horizon. Studies could also help determine if lower doses of the drugs than are currently used for pain relief can provide the cancer-prevention benefits without the risks.

"We need to keep looking to tailor the doses and tailor the compounds," he tells WebMD. "We know that they are effective. We just have to balance the side effects and adverse events."

American Cancer Society spokeswoman Debbie Saslow, PhD, tells WebMD that the studies examining the role of Cox-2 inhibitors and other NSAIDs for breast cancer prevention are inconclusive.

Saslow is director of breast and gynecological cancers for the American Cancer Society.

"The data are not yet strong enough to make any recommendations about using these drugs to prevent breast cancer or any cancer," she says. "There are too many unanswered questions about safety."

1 | 2

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
Breast Cancer Treatments Improving
Resolved To Quit Smoking
Woman getting mammogram
Screening Tests for Women
ovarian cancer overview slideshow
serious woman
what is your cancer risk
10 Ways to Revitalize Slideshow